APA

Belohlavkova P., Steinerova K., Karas M., Skoumalova I., Rohon P., Indrak K., Voglova J., Vrbacky F., Cmunt E., Necasova T., Kristkova Z., Trneny M., Zak P., Papajik T. & Faber E. (20200521). First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. : Leukemia research.

Chicago

Belohlavkova Petra, Steinerova Katerina, Karas Michal, Skoumalova Iva, Rohon Peter, Indrak Karel, Voglova Jaroslava, Vrbacky Filip, Cmunt Eduard, Necasova Tereza, Kristkova Zlatuse, Trneny Marek, Zak Pavel, Papajik Tomas and Faber Edgar. 20200521. First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. : Leukemia research.

Harvard

Belohlavkova P., Steinerova K., Karas M., Skoumalova I., Rohon P., Indrak K., Voglova J., Vrbacky F., Cmunt E., Necasova T., Kristkova Z., Trneny M., Zak P., Papajik T. and Faber E. (20200521). First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. : Leukemia research.

MLA

Belohlavkova Petra, Steinerova Katerina, Karas Michal, Skoumalova Iva, Rohon Peter, Indrak Karel, Voglova Jaroslava, Vrbacky Filip, Cmunt Eduard, Necasova Tereza, Kristkova Zlatuse, Trneny Marek, Zak Pavel, Papajik Tomas and Faber Edgar. First-line imatinib in elderly patients with chronic myeloid leukaemia from the CAMELIA registry: Age and dose still matter. : Leukemia research. 20200521.